spot_img
8.5 C
London
HomeInvestors HealthMcKesson, Oracle, Thoma Bravo among finalists to acquire Veradigm: report

McKesson, Oracle, Thoma Bravo among finalists to acquire Veradigm: report


Doctors using digital tablet together in hospital

Ariel Skelley

McKesson (NYSE:MCK) and Oracle (NYSE:ORCL) are among the finalists seeking to acquire electronic medical records company Veradigm (OTC:MDRX), Axios reported Sunday, citing sources.

According to the report, a deal is expected to top Veradigm’s $1B market cap due to the lower



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here